Target intelligence / Profile preview

Keratin and corneocyte proteins (KRT/CE proteins)

Target
KRT/CE proteins
Molecular classification
Structural protein, Intermediate filament, Cornified envelope protein
01

Overview

Keratins and corneocyte proteins are the primary structural components of the epidermis, specifically the stratum corneum. Keratins are a large family of intermediate filament proteins (Type I and Type II) that provide mechanical resilience and structural integrity to epithelial cells (UniProt, 2023). Corneocyte proteins, including filaggrin, loricrin, and involucrin, are essential for the formation of the cornified envelope, a highly insoluble barrier that protects against environmental insults and prevents transepidermal water loss (PubMed, PMID: 22403314). In dermatological conditions such as psoriasis, ichthyosis, and acne, there is often an overproduction or abnormal organization of these proteins, leading to hyperkeratosis and barrier dysfunction (NCBI, NBK470421). Therapeutic intervention targeting these proteins typically involves the use of keratolytic agents and retinoids. Keratolytics, such as salicylic acid and urea, work by increasing the moisture content of the skin and softening the keratin, which facilitates the shedding of the stratum corneum (StatPearls, 2023). Retinoids, on the other hand, act as ligands for nuclear receptors that regulate the expression of specific keratin genes, thereby normalizing the differentiation process of keratinocytes. While effective, treatments affecting these structural proteins can lead to side effects such as skin irritation and increased sensitivity to UV radiation due to the thinning of the protective outer layer.

Other names
CytokeratinsCornified envelope proteinsKeratin filamentsIntermediate filament proteinsEpidermal structural proteins
02

Mechanism of action

Keratolytic agents reduce corneocyte adhesion by dissolving the intercellular matrix or disrupting hydrogen bonds in keratin filaments; Retinoids modulate the transcription of keratin genes to normalize keratinocyte differentiation and proliferation.

03

Biological functions

Mechanical stabilitySkin barrier formationEpithelial cell integrityCornificationCytoskeletal organization
04

Disease associations

PsoriasisIchthyosisKeratosis pilarisEpidermolysis bullosaHyperkeratosisAcne vulgarisAtopic dermatitis
05

Safety considerations

Skin irritationErythemaPhotosensitivitySystemic toxicity (salicylism) with extensive use of high-concentration salicylic acidSkin barrier impairment
06

Interacting drugs

Salicylic acid

7 more in the full profile.

07

Biomarkers

Keratin 1 (KRT1)Keratin 10 (KRT10)Filaggrin (FLG)Loricrin (LOR)Involucrin (IVL)

Beyond the preview

Go deeper on Keratin and corneocyte proteins (KRT/CE proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin and corneocyte proteins (KRT/CE proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call